In vitro and in vivo antimalaial activities of artesunate
dc.contributor.author | Myint Oo | en_US |
dc.contributor.author | Myint Lwin | en_US |
dc.contributor.author | Kyin Hla Aye | en_US |
dc.contributor.author | Aung Khin | en_US |
dc.contributor.author | Hual Zik | en_US |
dc.date.accessioned | 2009-06-30T09:03:56Z | |
dc.date.available | 2009-06-30T09:03:56Z | |
dc.date.created | 1991-04-01 | en_US |
dc.date.issued | 1991-04-01 | en_US |
dc.description.abstract | Artesunate, a derivative of Quinghaosu (Artemisinine) was test for antimalarial activities against four isolates of Plasmodium falciparum in vitro and Plasmodium berghei- mouse model in vivo. The minimum inhibitory concentration of Artesunate in vitro was 6.0 p Mol per well whereas in vivo ED 90 was 1.4 mg/kg day. | en_US |
dc.identifier.citation | Myint Oo, Myint Lwin, Kyin Hla Aye, Aung Khin, Hual Zik. In vitro and in vivo antimalaial activities of artesunate. Myanmar Health Sciences Research Journal. 1991; 3(1): 14-18 | en_US |
dc.identifier.uri | https://imsear.searo.who.int/handle/123456789/127100 | |
dc.subject.mesh | Antimalarials | en_US |
dc.subject.mesh | Malaria-drug therapy | en_US |
dc.title | In vitro and in vivo antimalaial activities of artesunate | en_US |
Files
License bundle
1 - 1 of 1